EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neurotensin and Its Involvement in Female Hormone-Sensitive Cancers

Ninon Bertrand, Romane Mougel iD, George Riley, Marie Bruand, Guillaume Gauchotte iD, Mikaël Agopiantz iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111648 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ninon Bertrand und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, CHRU de Nancy, Université de Lorraine, F-54000 Nancy, France. Hauptthemen laut MEDLINE: Neurotensin, Receptors, Neurotensin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurotensin (NT) is a peptide involved in digestion, neuromodulation, and cancer progression. NT and its receptors (NTR1 and SORT1 mainly) have been widely studied in oncology. Data show that NT expression is under the control of sex steroid hormones, in particular estradiol. We focused on its involvement in three main female hormone-sensitive cancers, breast, ovarian, and endometrial cancer, in a narrative review. NT, NTR1, and SORT1 are mostly expressed in these three cancers, and their involvement in oncologic processes such as proliferation and invasion seems to match, as does their impact on prognosis for most. The development of NT receptor-targeted therapies, including theranostics and radioligand treatments, presents a promising avenue for personalized cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeurotensinReceptors, NeurotensinHumansFemaleBreast NeoplasmsEndometrial NeoplasmsOvarian NeoplasmsAdaptor Proteins, Vesicular TransportAnimalsSortilin

Stichwörter der Autor:innen

breast cancerendometrial cancerneurotensinovarian cancer

Substanzen

NeurotensinReceptors, NeurotensinAdaptor Proteins, Vesicular TransportSortilinneurotensin type 1 receptor

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, CHRU de Nancy, Université de Lorraine, F-54000 Nancy, France.
  • Department of Fertility Medicine, CHRU de Nancy, Université de Lorraine, F-54000 Nancy, France.
  • Department of Endocrinology, Diabetes and Nutrition, CHRU de Nancy, Université de Lorraine, F-54500 Vandœuvre-lès-Nancy, France.
  • Department of Radiation Therapy, Institut de Cancérologie de Lorraine, F-54500 Vandoeuvre-lès-Nancy, France.
  • Department of Pathology, CHRU de Nancy, Université de Lorraine, F-54500 Vandœuvre-lès-Nancy, France.
  • INSERM UMRS 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Université de Lorraine, F-54500 Vandœuvre-lès-Nancy, France.

ORCID-Profile: Romane Mougel, Guillaume Gauchotte, Mikaël Agopiantz

Zitieren

APA

Bertrand, N., Mougel, R., Riley, G., Bruand, M., Gauchotte, G., & Agopiantz, M. (2024). Neurotensin and Its Involvement in Female Hormone-Sensitive Cancers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111648

Vancouver

Bertrand N, Mougel R, Riley G, Bruand M, Gauchotte G, Agopiantz M. Neurotensin and Its Involvement in Female Hormone-Sensitive Cancers. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111648

BibTeX
@article{Bertrand2024,
  author = {Bertrand, Ninon and Mougel, Romane and Riley, George and Bruand, Marie and Gauchotte, Guillaume and Agopiantz, Mikaël},
  title = {Neurotensin and Its Involvement in Female Hormone-Sensitive Cancers},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111648}
}
Kostenlos starten →